Imation (GLAE) Stock Price, News & Analysis

Company Overview

GlassBridge Enterprises, Inc., through its subsidiaries, owns and operates an asset management business in the United States. It offers investment advisory services to third party investors through managed funds separate managed accounts. The company was formerly known as Imation Corp. and changed its name to GlassBridge Enterprises, Inc. in February 2017. GlassBridge Enterprises, Inc. was incorporated in 1996 and is headquartered in New York, New York.

Key Stats

• Today's Range: $25.00 to $25.00
• 50-Day Range: $25.00 to $25.00
• 52-Week Range: $20.00 to $32.00
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $750 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GLAE Stock Analysis - Frequently Asked Questions

How have GLAE shares performed this year?

Imation's stock was trading at $32.00 at the beginning of the year. Since then, GLAE stock has decreased by 21.9% and is now trading at $25.00.
View the best growth stocks for 2025 here.

How were Imation's earnings last quarter?

Imation Corporation (OTCMKTS:GLAE) issued its earnings results on Tuesday, August, 14th. The company reported ($0.39) earnings per share for the quarter. The firm had revenue of $8 million for the quarter.

When did Imation's stock split?

Imation shares reverse split on the morning of Wednesday, February 22nd 2017. The 1-10 reverse split was announced on Friday, February 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 21st 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Imation?

Shares of GLAE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Imation own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Imation investors own include Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Ampio Pharmaceuticals (AMPE), Amira Nature Foods (ANFI), Ampliphi Biosciences (APHB) and Athersys (ATHX).

Company Calendar

• Last Earnings: 8/14/2018
• Today: 6/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Finance
• Industry: FIN - MISC SVCS
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:GLAE
• Previous Symbol: NYSE:GLA
• CIK: 1014111
• Web: www.glassbridge.com
• Phone: (212) 220-3300
• Fax: 888-704-4200
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $100 thousand
• Price / Sales: 7.50
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 30,000
• Free Float: 26,000
• Market Cap: $750 thousand
• Optionable: Not Optionable
• Beta: 6.11